UNSPSC 85563401: Revision of nonautologous tissue substitute in nose, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in nose, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 09WK0KZ

UNSPSC 85563401 Revision of nonautologous tissue substitute in nose, open approach (Commodity) shows minimal alignment between its nominal medical-procedure scope and the actual work state and local governments are soliciting under this code. The recent opportunity record does not include state and local procurement activity for nasal tissue substitute procedures, revisions, or related otolaryngologic surgical services. Instead, the code has been applied to a range of occupational health surveillance, disability medical evaluation, surgical benefit administration, pharmacy benefit management, and temporary health professional staffing solicitations that bear no direct relationship to the code's stated medical definition.

The mismatch reflects a broader practice in which state and local procurement offices apply UNSPSC codes at a level of generality disconnected from actual commodity or service lines. Opportunities tagged under this code include the Washington State Department of Transportation's request for occupational medical surveillance services (due October 9, 2026), the City of Phoenix Retirement Office's RFP for disability medical record summary and independent medical evaluation services (due October 16, 2026, $750,000 over five years), the City of Long Beach's RFP for surgical and medical procedure carve-out benefits (due October 7, 2026), Harris County Juvenile Probation Department's RFI for emergency and specialty medical services for youth in custody (due September 25, 2026), and Collier County's RFP for pharmacy benefit management services (due April 9, 2026, $8.7 million historical annual spending). No recent solicitations target nasal tissue substitutes or related ENT procedures under this code. Business development professionals evaluating this code should treat it as a low-signal category offering no current actionable pipeline in the code's advertised specialty.